ÂÜÀòÂÒÂ×

​​​Dr. Shumilov brings vast experience in various CMC aspects of drug development & commercialization. Prior to joining Biosight, ​​​Dr. Shumilov served as a Team Leader in the Pharmaceutical Operations group and a CMC Projects Leader at the Innovative R&D division of Teva Pharmaceuticals Industries, where she successfully led the CMC aspects of Teva’s products for FDA approval. ​​​Dr. Shumilov specializes in the development of various sterile and solid dosage forms and drug-device combination products, from early preclinical stages to commercialization. In addition, ​​​Dr. Shumilov has an extensive experience in the scale-up, optimization, and validation of the manufacturing processes. Dr. Shumilov is a licensed pharmacist and holds a PhD in Pharmaceutical Sciences from the Hebrew University of Jerusalem.